Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia

被引:19
作者
Vallurupalli, S. [2 ]
Huesmann, G. [2 ]
Gregory, J. [3 ]
Jakoby, M. G., IV [1 ,2 ]
机构
[1] Univ Nevada, Sch Med, Dept Internal Med, Las Vegas, NV 89102 USA
[2] Univ Illinois, Coll Med, Dept Internal Med, Urbana, IL 61801 USA
[3] Univ Illinois, Coll Med, Dept Surg, Urbana, IL 61801 USA
关键词
central pontine myelinolysis; fluoroquinolones; hypoglycaemia; quadriplegia; Type 2 diabetes mellitus;
D O I
10.1111/j.1464-5491.2008.02465.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Central pontine myelinolysis (CPM) usually presents in chronic alcoholics and in patients in whom hyponatraemia has been corrected rapidly. However, CPM may occur in other clinical circumstances, including patients with severe hypoglycaemia. We describe the occurrence of CPM and quadriplegia in a patient who experienced fluoroquinolone-associated severe hypoglycaemia. Case report A 63-year-old man with Type 2 diabetes mellitus was admitted to hospital for resection of a large liposarcoma. Renal-dose levofloxacin was utilized as part of an antimicrobial regimen to treat post-operative peritonitis. On days 6-8 of levofloxacin therapy, the patient experienced recurrent hypoglycaemia despite total parenteral nutrition, 10% dextrose containing fluids and cessation of insulin therapy 3 days prior to the first hypoglycaemic episode. Hypoglycaemia resolved within 24 h of stopping levofloxacin. After a final and severe hypoglycaemic event, the patient developed quadriplegia and tonic left deviation of gaze. Magnetic resonance imaging revealed a high-intensity lesion in the central pons consistent with CPM. Conclusions Fluoroquinolones should be considered as a potential cause of hypoglycaemia. Severe hypoglycaemia has the potential to cause white matter lesions in the pons. Putative mechanisms include failure of membrane ion channels, oligodendrocyte apoptosis and oxidative stress of glucose reperfusion. Fluoroquinolone-associated hypoglycaemia and hypoglycaemia-induced quadriplegia are both rare and we believe this is the first case report linking the two events.
引用
收藏
页码:856 / 859
页数:4
相关论文
共 20 条
[1]   CENTRAL PONTINE MYELINOLYSIS - A HITHERTO UNDESCRIBED DISEASE OCCURRING IN ALCOHOLIC AND MALNOURISHED PATIENTS [J].
ADAMS, RD ;
VICTOR, M ;
MANCALL, EL .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1959, 81 (02) :154-172
[2]   Systemic antifungal agents - Drug interactions of clinical significance [J].
Albengres, E ;
Le Louet, H ;
Tillement, JP .
DRUG SAFETY, 1998, 18 (02) :83-97
[3]  
ANJOS MND, 1984, DIABETES CARE, V7, P613
[4]   Central pontine myelinolysis associated with a hypoglycemic coma in anorexia nervosa [J].
Bando, N ;
Watanabe, K ;
Tomotake, M ;
Taniguchi, T ;
Ohmori, T .
GENERAL HOSPITAL PSYCHIATRY, 2005, 27 (05) :372-374
[5]   Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis [J].
Böttcher, J ;
Kunze, A ;
Kurrat, C ;
Schmidt, P ;
Hagemann, G ;
Witte, OW ;
Kaiser, WA .
STROKE, 2005, 36 (03) :E20-E22
[6]   HYPOGLYCEMIA PRESENTING AS ACUTE TETRAPLEGIA [J].
DUARTE, J ;
PEREZ, A ;
CORIA, F ;
CLAVERIA, LE ;
GARCIA, MA .
STROKE, 1993, 24 (01) :143-143
[7]   Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: Nested case-control study [J].
Graumlich, JF ;
Habis, S ;
Avelino, RR ;
Salverson, SM ;
Gaddamanugu, M ;
Jamma, K ;
Aldag, JC .
PHARMACOTHERAPY, 2005, 25 (10) :1296-1302
[8]   Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water [J].
Hasegawa, Y ;
Formato, JE ;
Latour, LL ;
Gutierrez, JA ;
Liu, KF ;
Garcia, JH ;
Sotak, CH ;
Fisher, M .
STROKE, 1996, 27 (09) :1648-1655
[9]   Central and extrapontine myelinolysis: Then... and now [J].
Kleinschmidt-DeMasters, BK ;
Rojiani, AM ;
Filley, CM .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (01) :1-11
[10]   A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone [J].
Mohr, JF ;
McKinnon, PS ;
Peymann, PJ ;
Kenton, I ;
Septimus, E ;
Okhuysen, PC .
PHARMACOTHERAPY, 2005, 25 (10) :1303-1309